期刊
RAMBAM MAIMONIDES MEDICAL JOURNAL
卷 11, 期 2, 页码 -出版社
RAMBAM HEALTH CARE CAMPUS
DOI: 10.5041/RMMJ.10402
关键词
Bioresorbable scaffold; drug-eluting stent; stent thrombosis; target lesion failure; target lesion revascularization
Metallic drug-eluting stents have led to significant improvements in clinical outcomes but are inherently limited by their caging of the vessel wall. Fully bioresorbable scaffolds (BRS) have emerged in an effort to overcome these limitations, allowing a leave nothing behind approach. Although theoretically appealing, the initial experience with BRS technology was limited by increased rates of scaffold thrombosis compared with contemporary stents. This review gives a broad outline of the current BRS technologies and outlines the refinements in BRS design, procedural approach, lesion selection, and post-procedural care that resulted from early BRS trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据